BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kan A, Guo RP. The prognosis of subsequent surgical treatment in patients with sarcomatoid carcinoma in the liver: A retrospective study. Int J Surg 2018;55:145-51. [PMID: 29860126 DOI: 10.1016/j.ijsu.2018.05.736] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Wang X, Wang J, Yang X, Zhao H, Huo L. Pembrolizumab Exacerbates Thyroid Diseases Shown on FDG PET/CT. Clin Nucl Med 2020;45:1010-2. [PMID: 32910056 DOI: 10.1097/RLU.0000000000003251] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Numbere N, Zhang D, Agostini-Vulaj D. A rare histologic subtype of hepatocellular carcinoma, sarcomatoid hepatocellular carcinoma: report of a case. Hepat Oncol 2020;8:HEP33. [PMID: 34084452 DOI: 10.2217/hep-2020-0027] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Ge D, Luo Z, Mao R, Zhao H, Lv X, Zhao J, Zhou J, Huang Z, Zhang Y, Li Z, Bi X, Cai J. Development and Validation of a Nomogram-Based Prognostic Evaluation Model for Sarcomatoid Hepatocellular Carcinoma. Adv Ther 2020;37:3185-205. [PMID: 32436026 DOI: 10.1007/s12325-020-01357-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Zhang H, Chai S, Chen L, Wang Y, Cheng Y, Fang Q, Wu G, Wang X, Liang W, Xiao W. MRI Features of Hepatic Sarcomatoid Carcinoma Different From Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma. Front Oncol 2021;11:611738. [PMID: 34221954 DOI: 10.3389/fonc.2021.611738] [Reference Citation Analysis]
5 Cui T, Jin Y, Li B, Li J, Yue Y. Dynamic contrast-enhanced MR and PET/CT findings of uterine sarcomatoid carcinoma: a case report. BMC Womens Health 2020;20:223. [PMID: 33023546 DOI: 10.1186/s12905-020-01084-5] [Reference Citation Analysis]